AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on July 14, 2026

Topo Athletic Expands the Pro Series with the New Specter Elite
UNICEF Warns Children Are 'Growing Up Inside a Global Experiment' With AI — Dr.Look Ai Offers a Real-World Alternative
MotivationMetrics Launches Emotional Needs Scoring for Consumer Data in Prosper Model Factory
ScribeEMR Showcases AI Scribing and Virtual Coding Advances at FACHC Conference  
Influential Women Showcases Alexandria Hunter-Whalen: Speaker Empowering Leaders Through Executive Presence
Next Level Now Expands Professional Education With CPE-Approved Training Programs
Winsights Establishes Group of Leading Scientific and Clinical Advisors to Advance Research Through Patient Insights
Execution, Not Cuisine, Determines Restaurant Loyalty Winners, Incentivio Report Finds
Influential Women Profiles Jessica Figueroa: Pharmacy Leader Advancing Patient-Centered Home Infusion Care
 RealCISO Launches Continuous GRC & Compliance: 300+ Automated Checks Across Cloud, Identity, and Productivity Platforms
Brick Marketing Live Podcast Delivers Expert Insights on AI, SEO, GEO, AI Marketing, Content and Social Media
Regional Broadband Provider Saves $90,000 in Five Months With Automated Direct Mail
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
PLNT LAWSUIT: Planet Fitness, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton To Learn How They Might Recover Their Losses
Rapid7 to Report Second Quarter 2026 Financial Results on August 10
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
MKS Inc. Named in U.S. News & World Report’s 2026-2027 Best Companies to Work For
Tech entrepreneur Satish Jha to headline investor events in Boston, DC, and New York
AI Drug Discovery Investment Surges to $2+ Billion as Technology Cuts Development Timelines by 70%, Driven by Breakthrough Clinical Success Rates
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.